Publicacions en què col·labora amb Manuel Luque Ramirez (14)

2017

  1. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: A systematic review and meta-analysis

    Human Reproduction Update, Vol. 23, Núm. 4, pp. 390-408

2016

  1. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight

    Andrology, Vol. 4, Núm. 1, pp. 62-67

2014

  1. The striking similarities in the metabolic associations of female Androgen excess and male Androgen deficiency

    Human Reproduction, Vol. 29, Núm. 10, pp. 2083-2091

2008

  1. Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome

    European Journal of Endocrinology, Vol. 159, Núm. 3, pp. 225-232

  2. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery

    Obesity Surgery, Vol. 18, Núm. 8, pp. 1000-1006

2007

  1. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 7, pp. 2453-2461

  2. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses

    Diabetes Care, Vol. 30, Núm. 9, pp. 2309-2313

  3. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 6, pp. 2141-2148

  4. The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event

    Obesity Surgery, Vol. 17, Núm. 9, pp. 1199-1208

2006

  1. Adiponectin and resistin in PCOS: A clinical, biochemical and molecular genetic study

    Human Reproduction, Vol. 21, Núm. 9, pp. 2257-2265

  2. Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome [1]

    Diabetes Care

  3. The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women

    Human Reproduction, Vol. 21, Núm. 12, pp. 3157-3161

2005

  1. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 90, Núm. 7, pp. 4157-4162

  2. Body iron stores are increased in overweight and obese women with polycystic ovary syndrome

    Diabetes Care, Vol. 28, Núm. 8, pp. 2042-2044